Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managin...
Registos relacionados
-
Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
Por: Claudia Crimi, et al.
Publicado em: (2023-11-01) -
Nasal polyps impact in severe asthma patients: evidences from the SANI
Por: Giorgio Walter Canonica, et al.
Publicado em: (2020-08-01) -
Economic impact of a more extensive use of FENO testing on the Italian population with asthma
Por: Carla Rognoni, et al.
Publicado em: (2023-06-01) -
Asthma severity: the patient’s point of view
Por: Gabriella Guarnieri, et al.
Publicado em: (2024-12-01) -
Is Bronchiectasis (BE) Properly Investigated in Patients with Severe Asthma? A Real-Life Report from Eight Italian Centers
Por: Giovanna Elisiana Carpagnano, et al.
Publicado em: (2023-10-01)